Risk Factors Update Summary

• The Company incurred $249.7 million in costs related to Accelerating the Organization in 2023.
• The Company refined its assumption on renewal options, leading to an increase in Lease right-of-use asset and Lease liability.
• Restructuring costs primarily consist of employee termination benefits, totaling $180.5 million in 2023.
• Introduction of Form of 2021 Executive Time-Based Restricted Stock Unit Award Agreement. This affects stock-based compensation.
• The Company recognized a $71.7 million write-off of impaired software in 2023.
• Addition of Form of 2018 Executive Stock Option Award Agreement. This may impact executive compensation.
• The accrued balance related to the strategic initiative was $59.5 million at December 31, 2023.
• Total revenues increased from $23.2 billion in 2022 to $25.5 billion in 2023.
• Inclusion of Form of 2023 Executive Performance-Based Restricted Stock Unit Award Agreement. This impacts executive compensation.
• The restructuring costs in 2024 are expected to be similar to 2023, primarily consisting of professional service fees.
• Total assets increased from $50.4 billion in 2022 to $56.1 billion in 2023.
• Total operating income increased from $21.8 billion in 2022 to $22.5 billion in 2023.
• The Company increased its ownership stake from 20% to 48% in a strategic partnership for $1.8 billion.
• Total capital expenditures increased from $2.0 billion in 2022 to $2.4 billion in 2023.
• The Company had $127.2 million of RSUs vested in 2023, compared to $110.3 million in 2022.
• The Company evaluated subsequent events through January 30, 2023, including the completion of an acquisition.
• Net property and equipment increased from $23.8 billion in 2022 to $24.9 billion in 2023.